139 related articles for article (PubMed ID: 20635166)
1. Immunoexpression of galectin-3 in colorectal cancer and its relationship with survival.
Zaia Povegliano L; Oshima CT; de Oliveira Lima F; Andrade Scherholz PL; Manoukian Forones N
J Gastrointest Cancer; 2011 Dec; 42(4):217-21. PubMed ID: 20635166
[TBL] [Abstract][Full Text] [Related]
2. Prognostic values of galectin-3 and the macrophage migration inhibitory factor (MIF) in human colorectal cancers.
Legendre H; Decaestecker C; Nagy N; Hendlisz A; Schüring MP; Salmon I; Gabius HJ; Pector JC; Kiss R
Mod Pathol; 2003 May; 16(5):491-504. PubMed ID: 12748256
[TBL] [Abstract][Full Text] [Related]
3. Lack of Absent in Melanoma 2 (AIM2) expression in tumor cells is closely associated with poor survival in colorectal cancer patients.
Dihlmann S; Tao S; Echterdiek F; Herpel E; Jansen L; Chang-Claude J; Brenner H; Hoffmeister M; Kloor M
Int J Cancer; 2014 Nov; 135(10):2387-96. PubMed ID: 24729378
[TBL] [Abstract][Full Text] [Related]
4. C-erbB-2 expression is a better predictor for survival than galectin-3 or p53 in early-stage breast cancer.
Logullo AF; Lopes AB; Nonogaki S; Soares FA; Netto MM; Nishimoto IN; Brentani MM
Oncol Rep; 2007 Jul; 18(1):121-6. PubMed ID: 17549356
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of galectin-3 and cyclin D1 expression in undifferentiated nasopharyngeal carcinoma.
Acikalin MF; Etiz D; Gurbuz MK; Ozudogru E; Canaz F; Colak E
Med Oncol; 2012 Jun; 29(2):742-9. PubMed ID: 21553103
[TBL] [Abstract][Full Text] [Related]
6. Implication of the Galectin-3 in colorectal cancer development (about 325 Tunisian patients).
Arfaoui-Toumi A; Kria-Ben Mahmoud L; Ben Hmida M; Khalfallah MT; Regaya-Mzabi S; Bouraoui S
Bull Cancer; 2010 Feb; 97(2):E1-8. PubMed ID: 20080461
[TBL] [Abstract][Full Text] [Related]
7. The roles of JK-1 (FAM134B) expressions in colorectal cancer.
Kasem K; Gopalan V; Salajegheh A; Lu CT; Smith RA; Lam AK
Exp Cell Res; 2014 Aug; 326(1):166-73. PubMed ID: 24973512
[TBL] [Abstract][Full Text] [Related]
8. Galectin 7 (p53-induced gene 1): a new prognostic predictor of recurrence and survival in stage IV hypopharyngeal cancer.
Saussez S; Cucu DR; Decaestecker C; Chevalier D; Kaltner H; André S; Wacreniez A; Toubeau G; Camby I; Gabius HJ; Kiss R
Ann Surg Oncol; 2006 Jul; 13(7):999-1009. PubMed ID: 16788763
[TBL] [Abstract][Full Text] [Related]
9. Involvement of galectin-3 expression in colorectal cancer progression and metastasis.
Nakamura M; Inufusa H; Adachi T; Aga M; Kurimoto M; Nakatani Y; Wakano T; Nakajima A; Hida JI; Miyake M; Shindo K; Yasutomi M
Int J Oncol; 1999 Jul; 15(1):143-8. PubMed ID: 10375607
[TBL] [Abstract][Full Text] [Related]
10. Galectin-3 may serve as a marker for poor prognosis in colorectal cancer: A meta-analysis.
Wang C; Zhou X; Ma L; Zhuang Y; Wei Y; Zhang L; Jin S; Liang W; Shen X; Li C; Wang Y; Pang L
Pathol Res Pract; 2019 Oct; 215(10):152612. PubMed ID: 31474314
[TBL] [Abstract][Full Text] [Related]
11. The potential role of TGFbeta1, TGFbeta2 and TGFbeta3 protein expression in colorectal carcinomas. Correlation with classic histopathologic factors and patient survival.
Tsamandas AC; Kardamakis D; Ravazoula P; Zolota V; Salakou S; Tepetes K; Kalogeropoulou C; Tsota I; Kourelis T; Makatsoris T; Karavias D; Scopa CD; Bonikos DS; Kalofonos HP; Petsas T
Strahlenther Onkol; 2004 Apr; 180(4):201-8. PubMed ID: 15057430
[TBL] [Abstract][Full Text] [Related]
12. Expression of CIAPIN1 in human colorectal cancer and its correlation with prognosis.
Shi H; Zhou Y; Liu H; Chen C; Li S; Li N; Li X; Zhang X; Zhang H; Wang W; Zhao Q
BMC Cancer; 2010 Sep; 10():477. PubMed ID: 20815902
[TBL] [Abstract][Full Text] [Related]
13. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI
Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743
[TBL] [Abstract][Full Text] [Related]
14. Lack of prognostic significance of SOCS-1 expression in colorectal adenocarcinomas.
Ayyildiz T; Dolar E; Adim SB; Eminler AT; Yerci O
Asian Pac J Cancer Prev; 2014; 15(19):8469-74. PubMed ID: 25339048
[TBL] [Abstract][Full Text] [Related]
15. Sidedness Matters: Surrogate Biomarkers Prognosticate Colorectal Cancer upon Anatomic Location.
Ben-Aharon I; Goshen-Lago T; Sternschuss M; Morgenstern S; Geva R; Beny A; Dror Y; Steiner M; Hubert A; Idelevich E; Shulman K; Mishaeli M; Man S; Liebermann N; Soussan-Gutman L; Brenner B
Oncologist; 2019 Aug; 24(8):e696-e701. PubMed ID: 30755502
[TBL] [Abstract][Full Text] [Related]
16. Prokineticin 1 protein expression is a useful new prognostic factor for human sporadic colorectal cancer.
Nakazawa T; Goi T; Hirono Y; Yamaguchi A
Ann Surg Oncol; 2015 May; 22(5):1496-503. PubMed ID: 25331005
[TBL] [Abstract][Full Text] [Related]
17. Expression and significance of the Wip1 proto-oncogene in colorectal cancer.
Li ZT; Zhang L; Gao XZ; Jiang XH; Sun LQ
Asian Pac J Cancer Prev; 2013; 14(3):1975-9. PubMed ID: 23679302
[TBL] [Abstract][Full Text] [Related]
18. Expression of galectin-3 in gastric adenocarcinoma.
Gomes TS; Oshima CT; Forones NM; De Oliveira Lima F; Ribeiro DA
Indian J Med Res; 2014 Jul; 140(1):69-76. PubMed ID: 25222780
[TBL] [Abstract][Full Text] [Related]
19. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.
Deng Y; Kurland BF; Wang J; Bi J; Li W; Rao S; Lan P; Lin T; Lin E
Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802
[TBL] [Abstract][Full Text] [Related]
20. Expression of prokineticin-receptor2(PK-R2) is a new prognostic factor in human colorectal cancer.
Goi T; Kurebayashi H; Ueda Y; Naruse T; Nakazawa T; Koneri K; Hirono Y; Katayama K; Yamaguchi A
Oncotarget; 2015 Oct; 6(31):31758-66. PubMed ID: 26372733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
